Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Severe Plaque Psoriasis
Clinical trial NCT06640517 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06640517
- Sponsor
- Biocad
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-08
- Primary completion
- 2026-06-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.